IP Library Granted Patent US 12,447,331
Granted Patent B2
US 12,447,331 · App. 18/499,721 · Granted Oct 21, 2025

Extravascular implantable electrical lead having undulating configuration

Inventors: Mark T. Marshall (Cape Coral, FL); Gonzalo Martinez (Mendota Heights, MN); Vladimir P. Nikolski (Blaine, MN); Nathan L. Olson (Shoreview, MN); Kevin R. Seifert (Forest Lake, MN); Teresa A. Whitman (Dayton, MN)
Assignee: Medtronic, Inc.
A61N1/0504A61B5/287A61N1/05A61N1/3962A61N1/39622A61B5/686A61B5/6882A61N1/0563A61N1/057
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,447,331
App. No.
18/499,721
Filed
Nov 1, 2023
Granted
Oct 21, 2025
Kind
B2
Art Unit
3796
USPC
607/119
Abstract

This disclosure describes an implantable medical electrical lead and an ICD system utilizing the lead. The lead includes a lead body defining a proximal end and a distal portion, wherein at least a part of the distal portion of the lead body defines an undulating configuration. The lead includes a defibrillation electrode that includes a plurality of defibrillation electrode segments disposed along the undulating configuration spaced apart from one another by a distance. The lead also includes at least one electrode disposed between adjacent sections of the plurality of defibrillation sections. The at least one electrode is configured to deliver a pacing pulse to the heart and/or sense cardiac electrical activity of the heart.

Claims (46)

1. An implantable medical electrical lead comprising:

a lead body, wherein a distal portion of the lead body is configured to assume an undulating configuration defining a longitudinal axis, the undulating configuration defining at least a first peak displaced from the longitudinal axis in a first direction and a second peak displaced from the longitudinal axis in one of the first direction or a second direction opposite the first direction;

a first defibrillation electrode disposed on the first peak and a second defibrillation electrode disposed on the second peak; and

a separate electrode disposed on the distal portion between the first defibrillation electrode and the second defibrillation electrode,

wherein the distal portion is configured to assume a relatively straight configuration,

wherein the longitudinal axis extends through the first defibrillation electrode and the second defibrillation electrode when the distal portion is held within a lumen of a sheath,

wherein the distal portion is biased to assume the undulating configuration when the distal portion is displaced from the lumen of the sheath, and

wherein the separate electrode is disposed along the longitudinal axis when the distal portion assumes the relatively straight configuration and when the distal portion assumes the undulating configuration.

2. The implantable medical electrical lead of claim 1 , wherein the at least one of the first defibrillation electrode or the second defibrillation electrode is configured to deliver a defibrillation shock to a heart of a patient.

3. The implantable medical electrical lead of claim 1 , wherein the separate electrode is configured to perform one or both of:

deliver a pacing pulse to a heart of a patient; and

sense cardiac electrical activity of the heart of the patient.

4. The implantable medical electrical lead of claim 1 , wherein the separate electrode is a first separate electrode and further comprising a second separate electrode, wherein one of the first peak or the second peak is between the first separate electrode and the second separate electrode, and wherein the second separate electrode is disposed along the longitudinal axis when the distal portion assumes the relatively straight configuration and when the distal portion assumes the undulating configuration.

5. The implantable medical electrical lead of claim 1 , wherein the first peak and the second peak are within a common plane.

6. The implantable medical lead of claim 1 , wherein the first peak is located in a first plane and the second peak is located in a second plane different from the first plane.

7. The implantable medical lead of claim 1 , further comprising a conductor disposed within the lead body, wherein the first defibrillation electrode and the second defibrillation electrode are electrically connected to the conductor.

8. The implantable medical lead of claim 7 , wherein the conductor is connected to a pulse generator of an implantable medical device.

9. The implantable medical lead of claim 1 , further comprising:

a first conductor disposed within the lead body and electrically connected to the first defibrillation electrode; and

a second conductor disposed within the lead body and electrically connected to the second defibrillation electrode.

10. The implantable medical lead of claim 1 , further comprising a substantially linear portion supporting the distal portion, wherein the substantially linear portion is disposed along the longitudinal axis when the distal portion assumes the relatively straight configuration and when the distal portion assumes the undulating configuration.

11. The implantable medical lead of claim 1 , wherein the first defibrillation electrode is configured to assume a first curved shape comprising a first electrode peak displaced from the longitudinal axis in the first direction, and wherein the second defibrillation electrode is configured to assume a second curved shape comprising a second electrode peak displaced from the longitudinal axis in the one of the first direction or the second direction.

12. The implantable medical electrical lead of claim 11 , wherein the first electrode peak is disposed on the first peak of the distal portion, and wherein the second electrode peak is disposed on the second peak of the distal portion.

13. The implantable medical electrical lead of claim 1 ,

wherein the distal portion includes a first segment defining the first peak and a second segment defining the second peak,

wherein the distal portion includes a gap portion extending from the first segment to the second segment,

wherein the separate electrode is disposed on the gap portion, and

wherein an entirety of the gap portion is displaced from the first peak in the second direction and displaced from the second peak in the second direction.

14. The implantable medical electrical lead of claim 13 , wherein the separate electrode is disposed on the gap portion.

15. An implantable cardioverter-defibrillator (ICD) system comprising:

an implantable medical electrical lead comprising:

a lead body, wherein a distal portion of the lead body is configured to assume an undulating configuration defining a longitudinal axis, the undulating configuration defining at least a first peak displaced from the longitudinal axis in a first direction and a second peak displaced from the longitudinal axis in one of the first direction or a second direction opposite the first direction;

a first defibrillation electrode disposed on the first peak and a second defibrillation electrode disposed on the second peak; and

a separate electrode disposed on the distal portion between the first defibrillation electrode and the second defibrillation electrode,

wherein the distal portion is configured to assume a relatively straight configuration,

wherein the longitudinal axis extends through the first defibrillation electrode and the second defibrillation electrode when the distal portion is held within a lumen of a sheath,

wherein the distal portion is biased to assume the undulating configuration when the distal portion is displaced from the lumen of the sheath, and

wherein the separate electrode is disposed along the longitudinal axis when the distal portion assumes the relatively straight configuration and when the distal portion assumes the undulating configuration; and

an implantable cardioverter defibrillator (ICD) coupled to the implantable medical electrical lead, wherein the ICD comprises a control module and a therapy module, wherein the control module is configured to control the therapy module to deliver therapy to a patient via the implantable medical electrical lead.

16. The ICD system of claim 15 , wherein to control the therapy module to deliver the therapy, the control module is configured to control the therapy module to deliver a defibrillation shock to a heart of the patient using at least one of the first defibrillation electrode or the second defibrillation electrode.

17. The ICD system of claim 15 , wherein to control the therapy module to deliver the therapy, the control module is configured to control the therapy module to deliver a pacing pulse to a heart of the patient via the separate electrode.

18. The ICD system of claim 15 , wherein the ICD further comprises a sensing module configured to sense, via the separate electrode, cardiac electrical activity of a heart of the patient.

19. The implantable medical lead of claim 15 , wherein the implantable medical lead further comprises at least one of:

a substantially linear portion supporting the distal portion, wherein the substantially linear portion is disposed along the longitudinal axis when the distal portion assumes the relatively straight configuration and when the distal portion assumes the undulating configuration; or

a second separate electrode, wherein the separate electrode is a first separate electrode,

wherein one of the first peak or the second peak is between the first separate electrode and the second separate electrode, and wherein the second separate electrode is disposed along the longitudinal axis when the distal portion assumes the relatively straight configuration and when the distal portion assumes the undulating configuration.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2023
From: MARSHALL, MARK T.; MARTINEZ, GONZALO; NIKOLSKI, VLADIMIR P.; OLSON, NATHAN L.; SEIFERT, KEVIN R.; WHITMAN, TERESA A.
To: MEDTRONIC, INC.
Reel/Frame 065423/0268 →
Continuity (5)
Continuation 16890668 · Jun 2, 2020
Continuation 14963303 · Dec 9, 2015
Provisional Application 62262408 · Dec 3, 2015
Provisional Application 62089417 · Dec 9, 2014
Related Publication 20240058599A1 · Feb 22, 2024
References Cited (145)
US 2922024A · Arthur · 1960 [cited by applicant]
US 3496932A · Prisk et al. · 1970 [cited by applicant]
US 4030509A · Heilman et al. · 1977 [cited by applicant]
US 4161952A · Kinney et al. · 1979 [cited by applicant]
US 4355646A · Kallok et al. · 1982 [cited by applicant]
US 4374527A · Iversen · 1983 [cited by applicant]
US 4379462A · Borkan et al. · 1983 [cited by applicant]
US 4628934A · Pohndorf et al. · 1986 [cited by applicant]
US 4765341A · Mower et al. · 1988 [cited by applicant]
US 4922927A · Fine et al. · 1990 [cited by applicant]
US 4947866A · Lessar et al. · 1990 [cited by applicant]
US 4991603A · Cohen et al. · 1991 [cited by applicant]
US 5052407A · Hauser · 1991 [cited by examiner]
US 5105826A · Smits et al. · 1992 [cited by applicant]
US 5111811A · Smits · 1992 [cited by examiner]
US 5121754A · Mullett · 1992 [cited by applicant]
US 5174288A · Bardy et al. · 1992 [cited by applicant]
US 5176135A · Fain et al. · 1993 [cited by applicant]
US 5203348A · Dahl et al. · 1993 [cited by applicant]
US 5282845A · Bush et al. · 1994 [cited by applicant]
US 5325870A · Kroll et al. · 1994 [cited by applicant]
US 5336253A · Gordon et al. · 1994 [cited by applicant]
US 5342407A · Dahl et al. · 1994 [cited by applicant]
US 5387233A · Alferness et al. · 1995 [cited by applicant]
US 5456706A · Pless et al. · 1995 [cited by applicant]
US 5476498A · Ayers · 1995 [cited by examiner]
US 5476502A · Rubin · 1995 [cited by applicant]
US 5522874A · Gates · 1996 [cited by applicant]
US 5531782A · Kroll et al. · 1996 [cited by applicant]
US 5534022A · Hoffman et al. · 1996 [cited by applicant]
US 5545183A · Altman · 1996 [cited by applicant]
US 5545205A · Schulte et al. · 1996 [cited by applicant]
US 5654030A · Munshi et al. · 1997 [cited by applicant]
US 5683443A · Munshi et al. · 1997 [cited by applicant]
US 5709644A · Bush · 1998 [cited by applicant]
US 5800465A · Thompson et al. · 1998 [cited by applicant]
US 5810887A · Accorti, Jr. et al. · 1998 [cited by applicant]
US 5833714A · Loeb · 1998 [cited by applicant]
US 5849031A · Martinez et al. · 1998 [cited by applicant]
US 5853426A · Shieh · 1998 [cited by examiner]
US 5871531A · Struble · 1999 [cited by applicant]
US 5916243A · KenKnight et al. · 1999 [cited by applicant]
US 5922014A · Warman · 1999 [cited by examiner]
US 5922024A · Janzen et al. · 1999 [cited by applicant]
US 5925073A · Chastain et al. · 1999 [cited by applicant]
US 5991603A · Aoki et al. · 1999 [cited by applicant]
US 6066165A · Racz · 2000 [cited by applicant]
US 6157862A · Brownlee et al. · 2000 [cited by applicant]
US 6256541B1 · Heil et al. · 2001 [cited by applicant]
US 6321123B1 · Morris · 2001 [cited by examiner]
US 6327498B1 · Kroll · 2001 [cited by applicant]
US 6345198B1 · Mouchawar et al. · 2002 [cited by applicant]
US 6430449B1 · Hsu · 2002 [cited by examiner]
US 6650945B2 · Helland · 2003 [cited by examiner]
US 6658289B2 · Helland · 2003 [cited by applicant]
US 6721597B1 · Bardy et al. · 2004 [cited by applicant]
US 6721598B1 · Helland et al. · 2004 [cited by applicant]
US 7047086B2 · Taskiran et al. · 2006 [cited by applicant]
US 7313444B2 · Pianca et al. · 2007 [cited by applicant]
US 7465341B2 · Eliasson · 2008 [cited by applicant]
US 7668601B2 · Hegland et al. · 2010 [cited by applicant]
US 7684864B2 · Olson et al. · 2010 [cited by applicant]
US 7761150B2 · Ghanem et al. · 2010 [cited by applicant]
US 7890188B2 · Zhang · 2011 [cited by examiner]
US 7899555B2 · Morgan · 2011 [cited by examiner]
US 7917216B1 · Ryu et al. · 2011 [cited by applicant]
US 8017179B2 · Atanasoka et al. · 2011 [cited by applicant]
US 8498721B2 · Scheiner et al. · 2013 [cited by applicant]
US 9855414B2 · Marshall · 2018 [cited by examiner]
US 10137295B2 · Marshall et al. · 2018 [cited by applicant]
US 10252071B2 · Cao et al. · 2019 [cited by applicant]
US 10537731B2 · Reddy · 2020 [cited by applicant]
US 10576267B2 · Reddy et al. · 2020 [cited by applicant]
US 10661073B2 · Marshall et al. · 2020 [cited by applicant]
US 10675478B2 · Marshall · 2020 [cited by examiner]
US 10786679B2 · Reddy et al. · 2020 [cited by applicant]
US 11096757B2 · McFall et al. · 2021 [cited by applicant]
US 11534603B2 · Marshall et al. · 2022 [cited by applicant]
US 11813447B2 · Marshall · 2023 [cited by examiner]
US 20020035377A1 · Bardy et al. · 2002 [cited by applicant]
US 20020103507A1 · Helland · 2002 [cited by applicant]
US 20020103523A1 · Helland et al. · 2002 [cited by applicant]
US 20030050681A1 · Pianca · 2003 [cited by examiner]
US 20030078623A1 · Weinberg · 2003 [cited by examiner]
US 20030088187A1 · Saadat et al. · 2003 [cited by applicant]
US 20030105501A1 · Warman · 2003 [cited by examiner]
US 20030109914A1 · Westlund et al. · 2003 [cited by applicant]
US 20050209646A1 · Wanasek · 2005 [cited by applicant]
US 20050277990A1 · Ostroff · 2005 [cited by applicant]
US 20060020316A1 · Martinez et al. · 2006 [cited by applicant]
US 20060041295A1 · Osypka · 2006 [cited by applicant]
US 20060247753A1 · Wenger et al. · 2006 [cited by applicant]
US 20070250142A1 · Francis et al. · 2007 [cited by applicant]
US 20080046058A1 · Cross et al. · 2008 [cited by applicant]
US 20080046059A1 · Zarembo · 2008 [cited by examiner]
US 20080195163A1 · Scharmer · 2008 [cited by applicant]
US 20090248117A1 · Nippoldt et al. · 2009 [cited by applicant]
US 20090264780A1 · Schilling · 2009 [cited by applicant]
US 20090287266A1 · Zdeblick · 2009 [cited by applicant]
US 20090299447A1 · Jensen et al. · 2009 [cited by applicant]
US 20100063569A1 · Tockman et al. · 2010 [cited by applicant]
US 20100114195A1 · Burnes et al. · 2010 [cited by applicant]
US 20100121421A1 · Duncan et al. · 2010 [cited by applicant]
US 20100198041A1 · Christian et al. · 2010 [cited by applicant]
US 20100198284A1 · Zhou et al. · 2010 [cited by applicant]
US 20100305675A1 · Laske et al. · 2010 [cited by applicant]
US 20120029335A1 · Sudam et al. · 2012 [cited by applicant]
US 20120310239A1 · Stewart et al. · 2012 [cited by applicant]
US 20130023944A1 · Doerr · 2013 [cited by applicant]
US 20130338730A1 · Shiroff et al. · 2013 [cited by applicant]
US 20140052120A1 · Benscoter et al. · 2014 [cited by applicant]
US 20140330325A1 · Thompson-Nauman · 2014 [cited by examiner]
US 20140330327A1 · Thompson-Nauman et al. · 2014 [cited by applicant]
US 20150142010A1 · Min et al. · 2015 [cited by applicant]
US 20150306375A1 · Marshall et al. · 2015 [cited by applicant]
US 20150306410A1 · Marshall et al. · 2015 [cited by applicant]
US 20160158567A1 · Marshall et al. · 2016 [cited by applicant]
US 20170157413A1 · Anderson et al. · 2017 [cited by applicant]
US 20170266442A1 · Jackson · 2017 [cited by applicant]
US 20180133463A1 · Reddy · 2018 [cited by applicant]
US 20190336241A1 · Sanghera et al. · 2019 [cited by applicant]
US 20200000542A1 · McFall et al. · 2020 [cited by applicant]
US 20200282203A1 · Marshall et al. · 2020 [cited by applicant]
US 20210031048A1 · Marshall et al. · 2021 [cited by applicant]
US 20230109342A1 · Marshall et al. · 2023 [cited by applicant]
US 20230310840A1 · Marshall et al. · 2023 [cited by applicant]
JP 0440966A · 1992 [cited by applicant]
JP 06504214A · 1994 [cited by applicant]
JP 2005507745A · 2005 [cited by applicant]
WO 2003039647A2 · 2003 [cited by applicant]
WO 2009006331 · 2009 [cited by applicant]
Extended Search Report from counterpart European Application No. 21207501.4 dated Feb. 24, 2022, 7 pp. [cited by applicant]
Ganapathy et al., “Implantable Device to Monitor Cardiac Activity with Sternal Wires,” Pace, vol. 37, Dec. 2014, 11 pages. [cited by applicant]
Guenther et al., “Substernal Lead Implantation: A Novel Option to Manage OFT Failure in S-ICD patients,” Clinical Research Cardiology, Published On-line Oct. 2, 2014, 3 pages. [cited by applicant]
International Preliminary Report on Patentability from International Application No. PCT/US2015/064606, mailed Jun. 13, 2017, 7 pp. [cited by applicant]
International Search Report and the Written Opinion from International Application No. PCT/US2015/027478, Mailed Jul. 10, 2015, 9 pp. [cited by applicant]
International Search Report and the Written Opinion from International Application No. PCT/US2015/064606, Mailed Apr. 25, 2016, 11 pp. [cited by applicant]
International Search Report and Written Opinion of International Application No. PCT/US2015/064606, mailed Jun. 16, 2016, 10 pp. [cited by applicant]
International Search Report and Written Opinion of International Application No. PCT/US2023/027899 dated Oct. 31, 2023, 12 pp. [cited by applicant]
Marshall et al., Extravascular Implantable Electrical Lead Having Undulating Configuration, CN Application No. 201580067249.7, First Office Action Dispatched Oct. 23, 2019, English Translation, 8 pages. [cited by applicant]
Marshall, et al., “Extravascular Implantable Electrical Lead Having Undulating Configuration”, JP Application No. 2017-528882, Office Action Mailed Dec. 23, 2019, English Translation, 2 pages. [cited by applicant]
O'Callaghan et al., “Current Status of Implantable Cardioverter-Defibrillators”, Current Problems in Cardiology, vol. 22, No. 12, Dec. 1997, 66 pages. [cited by applicant]
Prosecution History from U.S. Appl. No. 14/963,303, dated Jun. 18, 2019 through Mar. 4, 2020, 79 pp. [cited by applicant]
Prosecution History from U.S. Appl. No. 16/890,668 dated Jul. 25, 2022 through Jul. 6, 2023, 72 pp. [cited by applicant]
Tung et al., “Initial Experience of Minimal Invasive Extra Cardiac Placement of High Voltage Defibrillator Leads,” Canadian Cardiovascular Congress 2007, Oct. 2007, vol. 23, Supplement SC, Abstract 0697, http://www.puls… [cited by applicant]